[Federal Register Volume 68, Number 130 (Tuesday, July 8, 2003)]
[Notices]
[Page 40686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-17123]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 8, 2003, Cody 
Laboratories, Inc., made application by letter to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

Diphenoxylate (9170)--Schedule II
Meperidine (9230)--Schedule II
Oxymorphone (9652)--Schedule II
Sufentanil (9740)--Schedule II

    The firm plans to manufacture bulk material for distribution to its 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCD) and must be filed no later than September 8, 2003.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-17123 Filed 7-7-03; 8:45 am]
BILLING CODE 4410-09-M